Display search results for ** instead (51 products)

Showing 1-10 of 51

28 Mar 2020  |  North America

Disruptive Innovations Fueling Improved NASH Management

Novel Drugs in late-stage clinical studies and improved diagnostic platforms are aiming to capture a major stake in the NASH diagnosis and treatment market

Non-alcoholic steatohepatitis (NASH) is a chronic liver condition whose prevalence across the globe continues to rise year on year. The liver disorder is considered very dangerous as its symtpoms can be mistaken for other liver disorders and conditions in addition to the disease quickly progressing to result in liver failure for the patients. The i...

USD 4,950.00
31 Mar 2020  |  North America

Medical Devices in 2025: An AI Impact Analysis

Transforming Medical Imaging, Patient Monitoring, Ophthalmic and Cancer Diagnostics through Implementation of AI

Medical device manufacturers are increasingly incorporating artificial intelligence (AI) in their systems with the aim to better assist healthcare providers and also improve care provided to the patients. AI systems have the ability to acquire data, deploy logical rules for processing the data, generate reasonable solutions and automatically recogn...

USD 4,950.00
30 Jan 2020  |  North America

Assessment of the US Revenue Cycle Management Market, Forecast to 2024

The Next Generation RCM is Prioritizing Consumer Centricity

This study primarily strives to: • Analyze the market forces affecting the utilization of next-generation Revenue Cycle Management (RCM) IT and service solutions among US hospitals and physician practices. • Evaluate the latest regulatory objectives that mandate episodic financial risk management initiatives. • Highlight the best ...

USD 4,950.00

USD 4,455.00 save 10 %

12 Aug 2020  |  North America

Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026

Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth

The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compou...

USD 4,950.00
23 Oct 2020  |  North America

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

USD 4,950.00
05 May 2020  |  North America

FROST RADAR™: Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry, 2020

Benchmarking Future Growth Potential

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

USD 4,950.00
20 Jul 2020  |  North America

Frost Radar™: US Healthcare Data Interoperability Market, 2020

Benchmarking Future Growth Potential

Interoperability has become a critical consideration for all health IT (HIT) applications. All the major healthcare stakeholders across the world acknowledge the need to invest in digital infrastructure capabilities to facilitate cross-continuum patient information exchanges and support evidence-based care, at scale. Regulatory agencies are embraci...

USD 4,950.00
05 Aug 2020  |  North America

Frost Radar™: Medical Devices in Atrial Fibrillation Market, 2020

Benchmarking Future Growth Potential

This Frost Radar™ analyzes emerging trends in the atrial fibrillation (AFib) landscape and profiles key market participants that deliver innovative solutions and maintain leadership in major segments in the care continuum, such as screening and monitoring, image-guided navigation and cardiac mapping, cardiac ablation, and left atrial appendage (L...

USD 4,950.00
12 Aug 2020  |  North America

New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025

AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities

Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...

USD 4,950.00
24 Jul 2020  |  North America

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies,...

USD 4,950.00

Showing 1-10 of 51